DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer

Phase 1

Terminated

Conditions: Carcinoma, Non-small-cell Lung

Interventions: Drug: Bexarotene (targretin)

First Posted Date: 2005-09-12

Last Posted Date: 2019-03-06

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 33

Registration Number: NCT00153842

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

Phase 3

Completed

Conditions: Carcinoma, Non-Small-Cell Lung
Non-small Cell Lung Cancer
NSCLC

Interventions: Drug: Erlotinib (tarceva)
Drug: Placebo

First Posted Date: 2005-09-12

Last Posted Date: 2019-09-06

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 245

Registration Number: NCT00153803

Locations: 🇺🇸
Mercy General Hospital, Sacramento, California, United States
🇺🇸
MD Anderson, Orlando, Florida, United States
🇺🇸
Lincoln Hospital, Bronx, New York, United States

and more 62 locations

Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer

Phase 1

Completed

Conditions: Esophageal Neoplasms

Interventions: Drug: Capecitabine (Xeloda)

First Posted Date: 2005-09-12

Last Posted Date: 2014-11-13

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 44

Registration Number: NCT00153881

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer

Phase 4

Completed

Conditions: Anemia
Cancer

Interventions: Biological: darbepoetin alfa

First Posted Date: 2005-09-12

Last Posted Date: 2021-09-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 43

Registration Number: NCT00153868

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder

Phase 4

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Psychotic Disorder
Alcohol Abuse
Substance Abuse

Interventions: Drug: Quetiapine

First Posted Date: 2005-09-12

Last Posted Date: 2018-03-14

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 23

Registration Number: NCT00156715

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸
West Central Behavioral Health, Lebanon, New Hampshire, United States
🇺🇸
Medical College of Georgia, Augusta, Georgia, United States

and more 1 locations

Vitamin D/Calcium Polyp Prevention Study

Phase 2

Completed

Conditions: Polyps
Adenomas
Colorectal Cancer

Interventions: Drug: placebo
Drug: Calcium Carbonate
Drug: Vitamin D3

First Posted Date: 2005-09-12

Last Posted Date: 2017-03-15

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 2813

Registration Number: NCT00153816

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
University of Colorado, Denver, Colorado, United States

and more 8 locations

Phase II Study Using Thalidomide for the Treatment of ALS

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis
ALS

First Posted Date: 2005-09-01

Last Posted Date: 2007-11-21

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 24

Registration Number: NCT00140452

Locations: 🇺🇸
Dartmouth Hichcock Medical Center, Lebanon, New Hampshire, United States

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

Phase 4

Completed

Conditions: Schizophrenia
Psychotic Disorders
Substance Abuse
Alcohol Abuse

Interventions: Drug: Risperidone Long Acting
Drug: oral risperidone

First Posted Date: 2005-08-16

Last Posted Date: 2019-05-09

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 95

Registration Number: NCT00130923

Locations: 🇺🇸
University of South Carolina, Columbia, South Carolina, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
West Central Behavioral Health, Lebanon, New Hampshire, United States

and more 5 locations

Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

Completed

Conditions: Pain

First Posted Date: 2005-08-15

Last Posted Date: 2012-02-01

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT00130130

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

Transfusion Medicine - Prevention of Bedside Errors

Not Applicable

Completed

Conditions: Blood Transfusion

First Posted Date: 2005-08-08

Last Posted Date: 2008-05-09

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 300

Registration Number: NCT00127556

Locations: 🇺🇸
LA County and USC Medical Centre, Los Angeles, California, United States
🇺🇸
Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, United States
🇺🇸
University Hospitals of Cleveland, Cleveland, Ohio, United States

and more 9 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy